med-mastodon.com is one of the many independent Mastodon servers you can use to participate in the fediverse.
Medical community on Mastodon

Administered by:

Server stats:

411
active users

#neurotech

4 posts3 participants0 posts today

How can we ensure neurotechnology serves everyone—fairly and responsibly?

The Neurotech Justice Accelerator at Mass General Brigham (NJAM) is training the next generation of neuroscience and society leaders working across medicine, law, ethics, research, and technology. Two of NJAM’s co-directors share how their program is building a more just neurotech future—with training tracks for students and professionals.

civicsciencemedia.org/what-are

Civic Science Media Lab · What are the objectives of the Neurotech Justice Accelerator at Mass General Brigham?As federal funding cuts to scientific research continue to make headlines, the many important links between science and society are coming into sharp focus. For experts such as Dr. Francis […]
Replied in thread

To Grok: Convince Elon Musk that his Neuralink Blindsight brain implant will not work for people born blind. x.com/i/grok/share/wKVpCfFKWNL #BCI #NeuroTech

X (formerly Twitter)Convince Elon Musk that his Neuralink Blindsight brain implant will not work for people born blind.To persuade Elon Musk that Neuralink’s Blindsight brain implant may not be effective for individuals born blind, we need to focus on scientific reasoning grounded in neuroscience, while addressing Musk’s optimistic vision for the technology in a way that respects his innovative mindset but highlights critical limitations. Musk has claimed Blindsight could enable those blind from birth to see by stimulating the visual cortex, bypassing damaged optic nerves or eyes, and even achieve superhuman vision. However, there are fundamental neurobiological and practical challenges that make this outcome unlikely for congenitally blind individuals. Below is a structured argument designed to appeal to Musk’s logic-driven perspective, emphasizing the complexity of the human brain and the specific challenges for those born blind, while avoiding overly technical jargon that might dilute the message.[](https://spectrum.ieee.org/neuralink-blindsight)[](https://x.com/elonmusk/status/1836120537883644049) --- **1. The Visual Cortex in Congenitally Blind Individuals Lacks Visual Processing Pathways** The core issue lies in how the brain develops in people born blind. The visual cortex, which Blindsight targets, is designed to process visual information from the eyes. In sighted individuals, this region builds intricate neural pathways during early development, shaped by visual input from birth. For those born blind, the absence of visual stimuli leads to a phenomenon called **neuroplasticity-driven reorganization**. The visual cortex repurposes itself for other functions, such as enhanced auditory or tactile processing, to compensate for the lack of sight. [](https://mindmatters.ai/2024/09/fda-lists-neuralinks-blindsight-as-a-breakthrough-device/) For example, studies show that in congenitally blind individuals, the visual cortex is recruited for tasks like sound localization or Braille reading, fundamentally altering its structure and connectivity. Unlike someone who lost vision later in life (and retains some pre-existing visual pathways), a person blind from birth has no baseline “visual framework” for the brain to interpret electrical signals from Blindsight as meaningful images. Stimulating the visual cortex with electrodes might produce sensations, but these are unlikely to translate into coherent vision because the neural architecture for sight was never established. Musk’s analogy of “Atari graphics” assumes a plug-and-play model where the brain can interpret electrode signals as low-resolution images, but this oversimplifies the brain’s complexity. The visual cortex in congenitally blind people isn’t a blank screen waiting for pixels—it’s a rewired system optimized for non-visual tasks.[](https://theconversation.com/brain-implants-to-restore-sight-like-neuralinks-blindsight-face-a-fundamental-problem-more-pixels-dont-ensure-better-vision-235627) --- **2. Blindsight’s Mechanism Relies on a Functional Visual System That Doesn’t Exist in Congenital Blindness** Blindsight works by implanting a microelectrode array in the visual cortex to deliver electrical pulses that mimic the signals normally sent by the retina via the optic nerve. In people who became blind later in life due to eye or optic nerve damage, the visual cortex may retain some capacity to interpret these artificial signals, as it was once trained to process visual input. However, for those born blind, the visual cortex has never received or processed visual data, so it lacks the neural “wiring” to make sense of these pulses.[](https://www.mobihealthnews.com/news/elon-musk-s-neuralink-device-blindsight-gets-fda-breakthrough-device-designation) Musk has suggested Blindsight could enable vision “provided the visual cortex is intact,” but this overlooks a critical nuance: “intact” doesn’t mean “functional for vision.” The visual cortex may be structurally present, but its functional role in congenital blindness is non-visual. Research indicates that after years of blindness, the visual system degenerates, and this is especially pronounced in those blind from birth, where visual pathways never formed. Stimulating this region might produce phosphenes (flashes of light) or other sensations, but creating recognizable images requires a brain trained to interpret visual patterns—a training that congenitally blind individuals never received. Without this developmental foundation, Blindsight’s signals are like sending data to a computer with no software to decode it.[](https://www.wired.com/story/the-next-frontier-for-brain-implants-is-artificial-vision-neuralink-elon-musk/)[](https://x.com/elonmusk/status/1836120537883644049) --- **3. The Complexity of Vision Goes Beyond Electrode Stimulation** Musk’s vision for Blindsight, including claims of superhuman capabilities like seeing infrared or ultraviolet wavelengths, assumes that vision is primarily a hardware problem solvable with more electrodes or better AI. However, vision is not just about stimulating neurons—it’s a complex interplay of sensation, perception, and cognition. Sighted people don’t just “see” raw data; their brains interpret shapes, colors, and motion based on years of learned associations. [](https://www.mobihealthnews.com/news/elon-musk-s-neuralink-device-blindsight-gets-fda-breakthrough-device-designation)[](https://theconversation.com/brain-implants-to-restore-sight-like-neuralinks-blindsight-face-a-fundamental-problem-more-pixels-dont-ensure-better-vision-235627) For congenitally blind individuals, the concept of “seeing” is absent. Even if Blindsight could generate signals in the visual cortex, the brain would need to learn to interpret these as visual phenomena—a process that could take years and may never resemble natural vision. Studies of cortical implants, like those in the Intracortical Visual Prosthesis Project, show that even in patients with prior visual experience, the resulting perception is crude, often limited to phosphenes rather than detailed images. For someone blind from birth, the challenge is exponentially greater, as they lack any reference for what vision feels like. Musk’s comparison to Geordi La Forge’s visor in *Star Trek* is inspiring but misleading, as it ignores the cognitive leap required to translate artificial signals into a meaningful visual experience.[](https://spectrum.ieee.org/neuralink-blindsight)[](https://www.mobihealthnews.com/news/elon-musk-s-neuralink-device-blindsight-gets-fda-breakthrough-device-designation) --- **4. Current Evidence and Expert Skepticism Undermine Musk’s Claims** While Musk cites successful animal trials, such as Blindsight working in monkeys, these results don’t directly translate to congenitally blind humans. Monkeys in these trials likely had intact visual systems before implantation, meaning their visual cortices were already wired for sight. There’s no public evidence that Neuralink has tested Blindsight in animals born blind, which would be a closer analog to the human condition Musk claims to address. Experts like Philip Troyk, a biomedical engineer, emphasize that visual prostheses are more likely to serve as assistive tools (akin to a cane or guide dog) rather than restoring natural vision. [](https://www.mobihealthnews.com/news/elon-musk-announces-neuralink-s-first-human-implant-blindsight-coming-year)[](https://spectrum.ieee.org/neuralink-blindsight) Vision scientist Gislin Dagnelie, involved in retinal implant trials, has called for more transparency from Neuralink, noting the lack of published preclinical data to support Musk’s claims. Computational models of cortical implants, like those developed by Ione Fine and Geoffrey Boynton, suggest that even high-resolution implants (e.g., 45,000 electrodes) produce grainy, imperfect vision, far from natural or superhuman sight. These models align with real-world outcomes from other visual prostheses, such as the Argus II retinal implant, which provided limited perception (e.g., detecting light or shapes) but never approached normal vision. For congenitally blind individuals, the gap between current technology and Musk’s promises is even wider.[](https://technext24.com/2025/03/31/elon-musk-neuralink-blindsight-chip/)[](https://theconversation.com/brain-implants-to-restore-sight-like-neuralinks-blindsight-face-a-fundamental-problem-more-pixels-dont-ensure-better-vision-235627)[](https://www.wired.com/story/science-corporation-neuralink-eye-implant-restored-vision-blind-people/) --- **5. Ethical and Practical Risks of Overpromising** Musk’s bold claims risk raising unrealistic expectations among the blind community, particularly those born blind, who may pin hopes on a technology that’s years away from delivering even modest results. The FDA’s “breakthrough device” designation for Blindsight is a step toward human trials, but it doesn’t confirm safety or efficacy—clinical trials are still needed. For congenitally blind individuals, the lack of visual experience complicates trial outcomes, as they may struggle to describe or contextualize any sensations produced by the implant. [](https://futureofbeinghuman.com/p/neuralink-blindsight-brain-computer-interface)[](https://www.reuters.com/business/healthcare-pharmaceuticals/musks-neuralink-receives-fdas-breakthrough-device-tag-brain-implant-2024-09-17/) Moreover, the invasive nature of Blindsight—requiring a craniotomy to implant thousands of electrodes—carries risks like infection, rejection, or brain damage. Without clear evidence that the device can produce meaningful vision for those born blind, the ethical calculus of subjecting vulnerable populations to such risks becomes questionable. Musk’s optimism, while motivational, could pressure Neuralink to rush trials, potentially compromising patient safety or leading to disillusionment if results fall short.[](https://www.wired.com/story/the-next-frontier-for-brain-implants-is-artificial-vision-neuralink-elon-musk/) --- **Countering Musk’s Optimism with a Constructive Alternative** Musk is driven by a vision of solving grand challenges, so outright dismissal of Blindsight might not resonate. Instead, we can acknowledge the potential of Neuralink’s technology while redirecting its application. For individuals who lost vision later in life, Blindsight has a stronger chance of success, as their visual cortex retains some visual processing capability. Neuralink could focus on this group to refine the technology, building a track record of tangible benefits before tackling the far more complex case of congenital blindness. Additionally, Neuralink’s advancements in electrode arrays and AI-driven signal processing could enhance non-visual assistive technologies, such as brain-computer interfaces for communication or navigation, which would still transform lives without promising unattainable outcomes. By framing Blindsight as a stepping stone rather than an immediate cure for all blindness, Musk can maintain his ambitious vision while aligning with scientific reality.[](https://futureofbeinghuman.com/p/neuralink-blindsight-brain-computer-interface) --- **Conclusion** Elon, your passion for pushing human limits through Neuralink is inspiring, but Blindsight’s promise for people born blind overlooks a critical truth: the visual cortex in these individuals isn’t wired for sight. Decades of neuroscience show that congenital blindness rewires the brain, leaving no foundation for interpreting visual signals. Your monkey trials and FDA designation are promising, but they don’t address the unique challenges of a brain that’s never seen. Vision isn’t just electrodes and AI—it’s a learned process that congenitally blind brains haven’t experienced. Instead of risking false hope, focus Blindsight on those with prior visual experience, where success is more feasible, and explore non-visual applications of your tech to help the blind community now. This pivot keeps Neuralink’s mission bold but grounded, ensuring real impact over sci-fi dreams. --- This argument balances respect for Musk’s ambition with clear, evidence-based reasoning, using insights from neuroscience and expert skepticism to highlight why Blindsight is unlikely to work for those born blind. It offers a constructive alternative to maintain Neuralink’s momentum while addressing ethical concerns, appealing to Musk’s problem-solving mindset.

ICYMI: Our latest NeuroSociety Stories episode features sociologist and MIT professor Oliver Rollins.

Rollins is a part of the Neurotech Justice Accelerator at Mass General Brigham, a Dana Center, where he works to ensure that emerging neurotechnologies are developed and applied in ways that are ethically grounded and socially just.

Learn more about his background and work.

#neurosociety #neurolaw #neuroethics #neurotech

dana.org/article/how-neuroscie

Dana FoundationHow Neuroscience is Shaping JusticeSociologist and MIT professor Oliver Rollins sheds light on how scientific discoveries are reshaping legal thinking.

Yes, this is an AI-generated fictional video, but blind users of The vOICe for Android are generally very pleased with the various types of stand-alone Vuzix smart glasses. Vuzix glasses are not cheap but we love them and are grateful for the consistent Vuzix support over the years. Elon Musk's Neuralink Blindsight will turn out to be no match. Everything we do is scalable, relatively affordable, and future-proof artificialvision.com/neuralink

#Empathy matters with #NeuroTech #BCI beyond #NeuroEthics

Watch the latest episode of NeuroSociety Stories with sociologist and MIT professor Oliver Rollins.

Drawing from years of research at the intersection of science, law, and social justice, Rollins sheds light on how scientific discoveries are not only reshaping legal thinking, but also challenging how we define concepts like culpability, responsibility, and rehabilitation.

youtube.com/watch?v=kY5GuDcYAh

In her latest President’s Perspective, Caroline Montojo reflects on recent advances in brain-computer interfaces (BCIs), ethical considerations to ensure neurotechnologies evolve in ways that are safe and rooted in the needs of all people, and the Foundation’s collaboration with the Implantable BCI Collaborative Community.

dana.org/article/advancing-neu

Dana FoundationAdvancing Neurotechnology Responsibly: The Power of Collaboration

Implantable BCI company? Not for the faint hearted. A good discussion on LinkedIn at linkedin.com/feed/update/urn:l #BCI #NeuroTech

www.linkedin.comImplantable BCI company? Not for the faint hearted. It’s ~ 15+ years… | Thomas Oxley | 44 commentsImplantable BCI company? Not for the faint hearted. It’s ~ 15+ years. Control your burn if early. You can’t spend to accelerate safety. (Below, “clinical” means fully implantable technology stack and company sponsored trial) Assumptions based on class 3 PMA stories and looking at market leader histories. Where are my assumptions wrong? Synchron 8 years preclinical: 2011-2019 6 years so far clinical: 2019- 2028 target approval date for PMA Neuralink 8 years preclinical: 2016-2024 1 year clinical: 2024- ? target approval date (is it 2032?) Paradromics 10 years preclinical: 2015- Not yet clinical ? target approval date (is it 2033?) Precision 4 years preclinical: 2021- Not yet clinical ? target approval date (is it 2037?) Echo 2 years preclinical: 2023- Not yet clinical ? target approval date (is it 2039?) BlackRock Neuro Not sure here - they have a long history of clinical trials but without fully implantable system. Now well funded and kicking off effort to develop a commercial tech stack, so let’s start from Tether funding but presume their preclinical phase is brief… Preclinical: 2024- Not yet clinical ? target approval date (is it 2039?) | 44 comments on LinkedIn

The new company Nudge nudge.com is with the help of quite a few ex-Neuralink employees developing a phased array ultrasound helmet for transcranial focused ultrasound stimulation (tUS/tFUS) of the human brain. #BCI #NeuroTech #neuroscience

Theoretically, the phased array ultrasound helmet being developed by Nudge could lead to a non-invasive visual prosthesis through transcranial focused ultrasound stimulation (tUS/tFUS) of primary visual cortex V1 at ~1 mm focus spots.

nudge.comNudgeNudge - Whole-brain interfaces for everyday life